Evaluation of a New Bi-Condylar Total Knee Prosthesis (TKP) With All-Ceramic Friction (The Forgotten Knee) (ForgottenKne)

January 13, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Evaluation of a New Bi-Condylar Total Knee Prosthesis (TKP) With All-Ceramic Friction

The results of TKP (Total Knee Prosthesis) are satisfactory but do not reach those of THP (Total Hip Prosthesis) in terms of indolence and function. By using an all-ceramic friction torque, identical to that of the hip, the promotor of this Clinical Investigation expects to obtain an improvement in term of indolence, ability to perform heavy activities, knee stability and an improvement in the long-term survival of TKP, while at the same time, a decrease in the rate of re-intervention in young patients.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to evaluate the all-ceramic knee prosthesis, according to clinical and radiological criteria of usual follow-up of a TKP for knee osteoarthritis, at 12 months.

Evaluation of clinical and radiographic endpoints at 12 months:

- Clinical: functional scores (Oxford and International Knee Society IKS), pain (from 0 to 6, better to worse outcome), knee mobility in flexion and extension (degrees), frontal and sagittal stability (in degrees and mm), joint sounds, Forgotten Joint Score (FJS).

The scores are mostly qualitative and all of them will be globally evaluated by the investigator regarding to the patient status.

-Radiographic: X-rays of the front and profile of the prosthesis, positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

MRI will be performed to evaluate the creation of a specific fibrous tissue around the joint that is expected with a ceramic on ceramic bearing.

Study Type

Interventional

Enrollment (Estimated)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Paris, France, 75010
        • Recruiting
        • Hopital Lariboisière
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Previously active adult under 70 years of age with disabling knee osteoarthritis resistant to medical treatments (anti-inflammatories, infiltrations, analgesics), with a frontal deformity < 10° for a primary implantation
  • Written informed consent by the patient
  • Patients affiliated to the French social security system

Exclusion Criteria:

  • Knee deformity > 10
  • Obesity (BMI > 30)
  • Inflammatory rheumatism
  • History of infection
  • Poor skin coverage at the knee joint
  • Known allergy to the materials used and/or anesthetic used in the surgery
  • Repeated falls, major neurological disorders, mental or neuromuscular disorders which can be a source of post-operative complications
  • Significant functional deficit of the collateral ligaments
  • Positive serum or urine pregnancy test for woman with child bearing potential. Pregnancy or within 48 hours post-partum or breast feeding women
  • Phobic patient refusing to have an MRI
  • Patient with a contraindication to have an MRI (active medical devices, metal implants, etc.)
  • Patient under legal protection
  • Patient participating in another Clinical Investigation
  • Post fracture osteoarthritis
  • Osteoporosis
  • Anatomical configuration not allowing the implant to be fixed (depending on size constraints)
  • Disabling comorbidity upon any resumption of physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CocKnee
Implementation of CocKnee
Implementation of a ceramic on ceramic knee prosthesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of clinical endpoint 1(Oxford score) at 12 months
Time Frame: 1 year

Clinical 1 :

Oxford functional score : 12 (good) to 60 (bad) 12 questions (1 normal to 5 discomfort )

1 year
Evaluation of clinical endpoint 2 (IKS score) at 12 months
Time Frame: 1 year

Clinical 2 :

International Knee Society (IKS) score :

  • objective component (symptoms) 25 points
  • subjective component:

    • expectation (pre or post surgery) 15 points
    • satisfaction 40 points
    • function 100 points
1 year
Evaluation of clinical endpoint 3 (Forgotten Joint score) at 12 months
Time Frame: 1 year

Clinical 3 :

Forgotten Joint Score (FJS) :

12 questions (0 normal to 4 discomfort ) = Total then FJScore = 100 - (Total x 25)

1 year
Evaluation of clinical endpoint 4 (Joint sounds) at 12 months
Time Frame: 1 year

Clinical 4:

Joint sounds :

5 questions, no score

1 year
Evaluation of clinical endpoint 5 (Pain) at 12 months
Time Frame: 1 year

Clinical 5:

Pain : 0 to 6

1 year
Evaluation of clinical endpoint 6 (Knee mobility) at 12 months
Time Frame: 1 year

Clinical 6:

Knee mobility :

Flexion (°) Extension (°)

1 year
Evaluation of clinical endpoint 7 (Knee stability) at 12 months
Time Frame: 1 year

Clinical 7:

Knee stability :

Frontal (° and mm) Sagittal (° and mm)

1 year
Evaluation of radiographic endpoints at 12 months
Time Frame: 1 year

Radiographic :

X-rays of the front and profile of the prosthesis : positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of clinical endpoint 1 (Oxford score) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 1 :

Oxford functional score : 12 (good) to 60 (bad) 12 questions (1 normal to 5 discomfort )

3 and 6 months
Evaluation of clinical endpoint 2 (IKS score) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 2 :

International Knee Society (IKS) score :

  • objective component (symptoms) 25 points
  • subjective component:

    • expectation (pre or post surgery) 15 points
    • satisfaction 40 points
    • function 100 points
3 and 6 months
Evaluation of clinical endpoint 3 (FJ Score) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 3 :

Forgotten Joint Score (FJS) :

12 questions (0 normal to 4 discomfort ) = Total then FJScore = 100 - (Total x 25)

3 and 6 months
Evaluation of clinical endpoint 4 (Joint sounds) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 4 :

Joint sounds :

5 questions, no score

3 and 6 months
Evaluation of clinical endpoint 5 (Pain) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 5 :

Pain : 0 to 6

3 and 6 months
Evaluation of clinical endpoint 6 (Knee mobility) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 6 :

Knee mobility :

Flexion (°) Extension (°)

3 and 6 months
Evaluation of clinical endpoint 7 (Knee stability) at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Clinical 7 :

Knee stability :

Frontal (° and mm) Sagittal (° and mm)

3 and 6 months
Evaluation of radiographic endpoints at 3 and 6 months and physical capabilities of the patient
Time Frame: 3 and 6 months

Radiographic :

X-rays of the front and profile of the prosthesis : positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

3 and 6 months
Evaluation of fibrous tissue
Time Frame: 1 year

Evaluation of fibrous tissue around the prosthesis:

Performance of ultrasounds and MRI at 3, 6 and 12 months postoperatively, allowing to evaluate and measure (in mm) the thickness and progression of fibrous tissue around the prosthesis.

1 year
Validation of the ancillary equipment used and the prosthesis surgical technique
Time Frame: 1 year
Notification of any malfunction noticed during the use of ancillary equipment
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal BIZOT, MD, Pr, APHP
  • Study Director: Laurent SEDEL, MD, Pr, CC/ Contact

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 19, 2024

Primary Completion (Estimated)

December 19, 2025

Study Completion (Estimated)

December 19, 2026

Study Registration Dates

First Submitted

July 16, 2024

First Submitted That Met QC Criteria

September 9, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 13, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • APHP190284
  • 2020-A02892-37 (Other Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Coc Knee

Subscribe